Search
/our-solutions/allergy-vaccines/production
A unique production approach, production_background_image.jpeg
,
From pollens to finished products, Raw materials, production_process_line_image_1.jpeg, Raw materials, API Production, production_process_line_image_2.jpeg, API Production, Finished production, production_process_line_image_3.jpeg, Formulation, Packaging…,
Producing allergy immunotherapy products, Left, Our commitment to maintaining the highest standards spans the entire manufacturing process, from the collection of raw materials, such as pollen, to t, production_text_image_1.jpeg
,
Our quality culture, Quality is key at a pharma company like ALK. It is our license to operate, a safety net for our patients and a necessity for our continued growth as a
,
Left, .field-items .field-item:nth-child(4) section {
padding-bottom: 0;
}
.field-items .field-item:nth-child(5) section {
padding-bottom: 0;
}
, prodcution_culture_image.png
,
Patient safety, product quality and efficacy, compliance, data integrity and stakeholder expectationsThat quality is built into our products, processe
,
ALK’s quality commitment By maintaining a strong focus on quality, we uphold our resilient heritage at ALK as a pioneer committed to helping people li
/node/1961
.h3-bold-heading {
font-size: 35px;
color: #002559;
font-weight: 600;
margin-bottom: 5px;
}
.reverse-container-text-image {
displ
,
.two-cards {
max-width: 1200px;
display: flex;
gap: 85px;
}
.cards {
max-width: 1200px;
display: flex;
,
Our quality culture, Quality is key at a pharma company like ALK. It is our license to operate, a safety net for our patients and a necessity for our continued growth as a
,
Left, Our quality cultureHigher quality is an important part of safeguarding ALK as a robust and compliant company with high quality products and service le, production.png
,
Patient safety, product quality and efficacy, compliance, data integrity and stakeholder expectationsThat quality is built into our products, processe
,
@media only screen and (min-width: 1024px) {
.paragraphs-item-image-with-related-text .image-with-related-link__image-text img {
width: 7
/our-science/healthcare-professionals/allergy-immunotherapy
Healthcare professionals, Allergy immunotherapy, Allergy-immunotherapy-banner.png
,
Targets the root cause of allergy by stimulating an immune responseAllergy immunotherapy (AIT) is the only treatment of allergic disease that addresse
,
Disease-modifying and protective effectTo achieve long-term sustained effect, where the benefits of the treatment continue after the treatment has end
,
Why has AIT disease-modifying effect?, <p><iframe src="https://www.alk.net/sites/default/files/2024-10/MoA%20AIT%20short%20video.mp4" frameborder="0" allowfulls, videoframe_5652.png, Watch video
,
.h3-bold-heading {
margin: 0;
font-weight: 600;
font-size: 35px;
color: #0a2455;
}
.clinical-trials-card-container {
displa
/our-science/healthcare-professionals/clinical-trials
Healthcare professionals, Clinical trials, Clinical Trials moved position.png, OUR KEY SLIT TRIALS
,
a {
color: #002559;
}
.h3-clinical-trials-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h3-clinical-trials-alt-h
,
Our key SLIT-tablet randomised controlled trialsOur SLIT-tablets build on the legacy of subcutaneous immunotherapy, which was discovered in the early
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.clinical-trials-card-container {
display: flex;
gap: 40px;
justify-content: center;
max-width: 1200px;
margin: 10px auto 0 a
,
P05239Disease area: Allergic rhinoconjunctivitisPhase: IIIFollow-up: Single-seasonRegion: North AmericaAge group: Children and adolescentsNo. of parti
,
Tree SLIT-tabletTT-03Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: 24 weeksRegion: Environmental exposure chamber (Europe)Age group: A
,
Ragweed SLIT-tabletP05233Disease area: Allergic rhinoconjunctivitisPhase: II/IIIFollow-up: One yearRegion: North AmericaAge group: AdultsNo. of partic
,
HDM SLIT-tabletMT-02Disease area: Allergic rhinoconjunctivitis and allergic asthmaPhase: II/IIIFollow-up: One yearRegion: EuropeAge group: Adolescents
,
P003Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: Up to 76 weeksRegion: Environmental exposure chamber (Europe)Age group: AdultsNo. of
,
Compliance with guidelinesIn compliance with industry guidelines, more information about all our clinical trials can be found via the freely public re
/our-science/healthcare-professionals/our-data/real-world-evidence
Healthcare professionals, Real-world evidence, Real-world evidence banner.png, REWEAL
,
.h3-bold-heading {
margin: 0;
font-weight: 600;
font-size: 35px;
color: #0a2455;
}
.h3-real-world-heading {
font-size: 30px;
col, setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-promo-lis…,
Why was REWEAL initiated?, Real-world evidence img 1.png, Watch video
,
.h3-real-world-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2-real-world-heading {
margin: 0;
font-weight: 300
,
Time to REACT in AITWith the REACT-study we aim to complement existing evidence from randomised controlled trials and address some key unanswered ques
,
REACT study design, Real-world evidence img 4.png, Read infographic
,
Real-world evidence img 3.png, The REACT study, a retrospective cohort study, Go to publication, Real-world evidence img 3.png, Subgroup analyses of the REACT study, Go to publication
/our-science/henning-lowenstein-research-award
Young scientists, The Henning Løwenstein Research Award, ALK Lab Banner Final.png, Application guidelines
,
#application-guidelines {
scroll-margin-top: 100px;
}
.h3-reward-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2
,
.container-text-image {
display: grid;
grid-template-columns: 1fr 1.1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-column:
,
ALK awards young scientists for excellenceIn ALK, we believe that reinforced efforts in research on the characteristics and treatment of respiratory a
,
2024 Henning Løwenstein Research Award - won by Kelly Bruton, Kelly Bruton - winner 2024.png, Watch ceremony
,
#application-guidelines {
padding-top: 3em;
padding-bottom: 1em;
}
Application guidelinesNext call for applications will be posted here.
,
.subheading-padding-edited {
padding-top: 0;
font-size: 30px;
font-family: Seven;
color: #002559;
}
li::marker {
color: red;
}
,
EvaluationAn international Scientific Board will evaluate the applications. The members in 2024 are: Dr. Henning Løwenstein, Owner and chairman of the
,
Previous award ceremonies and winners
,
Kelly Bruton img1.png, 2024 Henning Løwenstein Research Award - won by Kelly Bruton, Watch ceremony, Julia Esser-von Bieren img edited.png, 2021 Henning Løwenstein Research Award - won by Julia Esser-von Bieren, Watch ceremony
,
2024: Kelly Bruton, Stanford University, United States of America 2021: Julia Esser-von Bieren, Technical University, Munich, Germany
,
The ARIA-EUFOREA Henning Løwenstein Research Award2019: Kornel Golebski, University of Amsterdam, the Netherlands
,
The WAO Henning Løwenstein Research Award2015: Stefanie Eyerich, Technical University and Helmholtz Center, Munich, Germany 2013: Bianca Schaub, Ludwi
,
The Henning Løwenstein Research Award2005: Omid Akbari, Harvard University, United States of America 2004: Christopher Lynn Kepley, Commonwealth Unive, setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-p…,
* If the winner is from a country where local legislation or medicolegal regulation prevents the transfer of monetary awards from the pharmaceutical i, setTimeout(datalayerEvent, 1500);
function datalayerEvent() {
jQuery(".paragraphs-item-content…
/our-science/healthcare-professionals
Healthcare professionals, Welcome, Healthcare-professionals-banner-new.png, Allergy Immunotherapy
,
a {
color: #002559;
}
.paragraphs-item-section-frontpage-top .field-name-field-title-label {
color: #ffffff;
}
.field-items .field-
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.h3-bold-heading {
font-size: 35px;
color: #002559;
font-weight: 600;
margin-bottom: 5px;
}
.reverse-container-text-image {
displ
,
.two-cards {
max-width: 1200px;
display: flex;
gap: 85px;
}
.cards {
max-width: 1200px;
display: flex;
/our-science/healthcare-professionals/our-data/clinical-data-sharing
Sharing our clinical trials data, Kids playing ball.png, How to apply
,
.timeline-move {
left: 0 !important;
}
.h3-clinical-trials-data-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h
,
.main-container-text-block-cta {
display: flex;
justify-content: space-between;
max-width: 1200px;
margin: 0 auto;
align-item
,
.reverse-container-text-image {
display: grid;
grid-template-columns: 1.1fr 1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-
,
Synopses
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.cards-second-row {
max-width: 770px;
display: flex;
justify-content: space-between;
gap: 30px;
margin: 0 auto;
,
.clinical-list-container {
display: flex;
flex-wrap: wrap;
justify-content: space-between;
margin: 0 15px 0 15px;
max-width:
,
Grass SLIT-tabletGT-21 (EudraCT ID: 2009-011235-12)GT-01GT-02GT-03GT-04GT-07GT-08+ext (EudraCT ID: 2004-000083-27)GT-09 (EudraCT ID: 2005-004962-18)GT
,
Ragweed SLIT-tabletP008 (EUDRACT ID: 2014-004341-27RT-01P06081P05233P05234 (EudraCT ID: 2008-003864-20)P05751
,
Tree SLIT-tabletTT-04 (EUDRACT ID: 2015-004821-15TT-06 (EUDRACT ID: 2020-004372-17
,
Other productsSU-G-01 (EUdRACT ID: 2020-000455-12JX-A-03
,
.timeline-item.active .timeline-item-circle{
background-color: #0a2455 !important;
}
.timeline-item:hover .timeline-item-circle{
backgr
/our-science/healthcare-professionals/our-data
Healthcare professionals, Our data, Our data banner.png, Clinical trials
,
.h3-bold-heading {
font-size: 35px;
color: #002559;
font-weight: 600;
margin-bottom: 5px;
}
.h3-our-data-heading {
font-size: 30
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
/our-science
Our science, Our science new banner - ALK banner.png, Scientific focus
,
At the core of ALK, innovation thrives. We have spent the past 100+ years pioneering within the field of allergy with the continued purpose of helping
,
.h2-our-science-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
}
.h3-our-science-headi
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.reverse-container-text-image {
display: grid;
grid-template-columns: 1.1fr 1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-
,
.container-text-image {
display: grid;
grid-template-columns: 1fr 1.1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-column:
,
AnaphylaxisAnaphylaxis is a severe and acute allergic reaction that occurs when the immune system overreacts to a certain allergen. The health burden
,
New adjacent areasWe are founded in allergology and immunology and are leveraging our deep knowledge in ”Type 2” immune mechanisms and dysregulation w
,
Development pipelineOur commitment to helping people and families living with the burden of allergy drives our discovery and development of innovative
,
Development Pipeline table.png
,
For more information, please refer to our company announcements. For healthcare professionals, more information can be found here.Read more about our
,
Clinical trialsInformation about our clinical trials can be found via the freely public registries clinicaltrialregister.eu, clinicaltrials.gov or on